Načítá se...
Tau oligomers in cerebrospinal fluid in Alzheimer's disease
OBJECTIVE: With an increasing incidence of Alzheimer's disease (AD) and neurodegenerative tauopathies, there is an urgent need to develop reliable biomarkers for the diagnosis and monitoring of the disease, such as the recently discovered toxic tau oligomers. Here, we aimed to demonstrate the p...
Uloženo v:
| Vydáno v: | Ann Clin Transl Neurol |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5376754/ https://ncbi.nlm.nih.gov/pubmed/28382304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.382 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|